Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates

MLA

Camellia W. Adams, et al. “Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates.” The Journal of Immunology, vol. 182, June 2009, pp. 7663–71. EBSCOhost, https://doi.org/10.4049/jimmunol.0804182.

APA

Camellia W. Adams, Samantha Lien, Julia Qiu, Jonathan S. Marvin, Maya K. Leabman, Henry B. Lowman, Melissa A. Starovasnik, & Yeung Yik Andy. (2009). Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates. The Journal of Immunology, 182, 7663–7671. https://doi.org/10.4049/jimmunol.0804182

Chicago

Camellia W. Adams, Samantha Lien, Julia Qiu, Jonathan S. Marvin, Maya K. Leabman, Henry B. Lowman, Melissa A. Starovasnik, and Yeung Yik Andy. 2009. “Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates.” The Journal of Immunology 182 (June): 7663–71. doi:10.4049/jimmunol.0804182.